Fortrea Holdings Inc. (FTRE) vs Disc Medicine, Inc. (IRON)
A side-by-side comparison of Fortrea Holdings Inc. and Disc Medicine, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FTRE
Fortrea Holdings Inc.
$21.55HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
IRON
Disc Medicine, Inc.
$62.65HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — FTRE vs IRON
growth of $100 · dividends reinvested · last 3yFTRE -34.0% (-12.9%/yr)IRON +28.1% (+8.6%/yr)IRON compounded faster over this window
FTRE IRON
FTRE vs IRON: by the numbers
- •IRON is the larger company ($2.41B vs $2.05B market cap).
- •Both run net losses; IRON's is the smaller (0.00% vs -3.18% net margin).
Metrics side by side
Valuation
| Metric | FTRE | IRON |
|---|---|---|
| Forward P/E | 25.62 | N/A |
| P/S ratio | 0.77 | N/A |
| P/B ratio | 3.91 | 3.73 |
| EV / EBITDA | 33.57 | N/A |
| FCF yield | 7.35% | N/A |
Profitability
| Metric | FTRE | IRON |
|---|---|---|
| Gross margin | 17.11% | 0.00% |
| Operating margin | 0.41% | 0.00% |
| Net margin | -3.18% | 0.00% |
| ROE | -16.25% | -38.17% |
| ROIC | 0.62% | -38.21% |
Growth (annualized)
| Metric | FTRE | IRON |
|---|---|---|
| Revenue CAGR (5Y) | 1.09% | N/A |
| FCF CAGR (5Y) | -12.98% | N/A |
| Total return CAGR (5Y) | N/A | 10.70% |
Go deeper
Dig into the metrics
Fortrea ROEDisc Medicine ROEFortrea operating marginDisc Medicine operating marginFortrea revenue growthDisc Medicine revenue growthFortrea free cash flowDisc Medicine free cash flow
Fortrea & Disc Medicine appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.